Zhang X, Yu L, Geng C. Expression characteristics, molecular mechanisms, and clinical significance of DICER1 in breast cancer. Front Genet. 2025;16:1586287. https://doi.org/10.3389/fgene.2025.1586287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song K-H, Jung S-Y, Park J-I, et al. SLAMF1 expression in breast cancer cells delays tumor growth in vivo. Sci Rep. 2025;15(1):31247. https://doi.org/10.1038/s41598-025-17322-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song P, Zhang L, Qiu H, et al. The role of RANBP1 in regulating MiRNA expression and apoptosis in breast cancer cells. Genes Genomics. 2025. https://doi.org/10.1007/s13258-025-01664-5.

Article  PubMed  PubMed Central  Google Scholar 

Li P, Wei L, Li M, Yang H. ESCO2 drives breast cancer proliferation and metastasis through PI3K/AKT/mTOR phosphorylation: a potential therapeutic target. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2025;1872(8):120043. https://doi.org/10.1016/j.bbamcr.2025.120043.

Article  CAS  PubMed  Google Scholar 

Qian Y, Che Y, Li S, et al. POC1A induces epithelial-mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer. Mol Med. 2025;31(1):280. https://doi.org/10.1186/s10020-025-01315-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai T, Xu Z, Li Y, et al. Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages. Cancer Cell Int. 2025;25(1):293. https://doi.org/10.1186/s12935-025-03932-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Q, Zhang X-L. Roles of core fucosylation modification in immune system and diseases. Cell Insight. 2025;4(1):100211. https://doi.org/10.1016/j.cellin.2024.100211.

Article  PubMed  Google Scholar 

Ma X, Li M, Wang X, Qi G, Wei L, Zhang D. Sialylation in the gut: from mucosal protection to disease pathogenesis. Carbohydr Polym. 2024;343:122471. https://doi.org/10.1016/j.carbpol.2024.122471.

Article  CAS  PubMed  Google Scholar 

De Vellis C, Pietrobono S, Stecca B. The role of glycosylation in melanoma progression. 2021;10(8):2136.

Google Scholar 

Jian Y, Yang K, Li J, et al. Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma. Cancer Cell Int. 2025;25(1):36. https://doi.org/10.1186/s12935-025-03640-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen F, Gao K, Li Y, et al. ST3GAL1 promotes malignant phenotypes in intrahepatic cholangiocarcinoma. Mol Cell Proteomics. 2024;23(9):100821. https://doi.org/10.1016/j.mcpro.2024.100821.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, Jin Y, Gao S, et al. Prognostic signature and therapeutic value based on membrane lipid biosynthesis-related genes in breast cancer. J Oncol. 2022;2022:7204415. https://doi.org/10.1155/2022/7204415.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garnham R, Geh D, Nelson R, et al. ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Commun Biol. 2024;7(1):276. https://doi.org/10.1038/s42003-024-05924-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deminami M, Hashimoto M, Takahashi H, et al. Androgens suppress the sialyltransferases ST3GAL1 and ST3GAL4 and modulate mucin 10 glycosylation in the submandibular gland, related to sex differences in commensal microbiota composition in mice. Biosci Biotechnol Biochem. 2025;89(2):241–54. https://doi.org/10.1093/bbb/zbae175.

Article  CAS  PubMed  Google Scholar 

Hao H, Yang L, Wang B, Sang Y, Liu X. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients. Open Life Sci. 2023;18(1):20220784. https://doi.org/10.1515/biol-2022-0784.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdulla M, Traiki TB, Vaali-Mohammed MA, et al. Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer. Int J Oncol. 2022. https://doi.org/10.3892/ijo.2022.5312.

Article  PubMed  PubMed Central  Google Scholar 

Hao H, Wang B, Yang L, et al. miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. Aging. 2023;15(14):6993–7007. https://doi.org/10.18632/aging.204887.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Su W, Chen J, Ouyang P, Gong J. ST3GAL4 promotes tumorigenesis in breast cancer by enhancing aerobic glycolysis. Hum Cell. 2024;38(1):1. https://doi.org/10.1007/s13577-024-01137-z.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Wang C, Lu T, et al. ST6GALNAC4 promotes diffuse large b-cell lymphoma progression via mediating sialylation of Bmpr-1B at Thr24. Blood. 2024;144:833. https://doi.org/10.1182/blood-2024-210107.

Article  Google Scholar 

Szabo R, Dobie C, Montgomery AP, Steele H, Yu H, Skropeta D. Synthesis of α-hydroxy-1,2,3-triazole-linked sialyltransferase inhibitors and evaluation of selectivity towards ST3GAL1, ST6GAL1 and ST8SIA2. ChemMedChem. 2024;19(16):e202400088. https://doi.org/10.1002/cmdc.202400088.

Article  CAS  PubMed  Google Scholar 

Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9(11):1102. https://doi.org/10.1038/s41419-018-1101-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan Q, Chen X, Han Y, et al. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway. Int J Cancer. 2018;143(9):2319–30. https://doi.org/10.1002/ijc.31737.

Article  CAS  PubMed  Google Scholar 

Chen YX, Zhao GN, Gao QL. Aberrant sialylation in ovarian cancer: orchestrating progression, metastasis, and therapeutic hurdles. Current medical science. 2025;45(3):395–404. https://doi.org/10.1007/s11596-025-00041-3.

Article  CAS  PubMed  Google Scholar 

Lin WD, Fan TC, Hung JT, et al. Sialylation of CD55 by ST3GAL1 facilitates immune evasion in cancer. Cancer Immunol Res. 2021;9(1):113–22. https://doi.org/10.1158/2326-6066.Cir-20-0203.

Article  CAS  PubMed  Google Scholar 

Zhang N, Lin S, Cui W, Newman PJ. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation. Blood Adv. 2022;6(13):3945–55. https://doi.org/10.1182/bloodadvances.2022007001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maeda T, Hiraki M, Jin C, et al. MUC1-C induces PD-L1 and immune evasion in triple-negative breast cancer. Cancer Res. 2018;78(1):205–15. https://doi.org/10.1158/0008-5472.Can-17-1636.

Article  CAS  PubMed  Google Scholar 

Tao S, Li H, Ma X, et al. Methylation-mediated silencing of MicroRNA-497 promotes breast cancer progression through up-regulation of mucin1. Front Oncol. 2020;10:552099. https://doi.org/10.3389/fonc.2020.552099.

Article  PubMed  PubMed Central